You are here

Justice News

Department of Justice
U.S. Attorney’s Office
District of New Hampshire

FOR IMMEDIATE RELEASE
Monday, January 27, 2020

Manchester Man Sentenced to 42 Months for Fentanyl Trafficking

            CONCORD – Abelino Morales-Padilla, 38, of Manchester, was sentenced to 42 months in federal prison for fentanyl trafficking on Friday, United States Attorney Scott W. Murray announced today.

            According to court documents and statements made in court, in October 2018, Morales-Padilla conspired with others to distribute fentanyl.  On October 16, 2018, a confidential informant informed police that Morales-Padilla would be coming from Massachusetts to New Hampshire with a large quantity of fentanyl.  Police officers identified the car and stopped Morales-Padilla for traffic violations in Londonderry.  Law enforcement officers later located approximately 424 grams of fentanyl inside the vehicle.

            Morales-Padilla previously pleaded guilty on July 30, 2019. 

            “Interstate fentanyl traffickers endanger our citizens by making this deadly substance available for sale in New Hampshire,” said U.S. Attorney Murray.  “We will not tolerate this hazardous and unlawful conduct.  Those who transport fentanyl into the Granite State will be prosecuted and sentenced to federal prison.”

            “Morales-Padilla and the other members of this drug trafficking organization believed they could operate with impunity selling fentanyl and other deadly narcotics for profit with no regard to human life,” said Jason J. Molina, acting special agent in charge for HSI Boston. “HSI and our law enforcement partners remain committed to putting any organization that is flooding our streets with fentanyl out of business and behind bars.”

            This matter was investigated by the U.S. Immigrations and Customs Enforcement’s Homeland Security Investigations and the New Hampshire State Police.  The case is being prosecuted by Assistant U.S. Attorney John Davis. 

###

Topic(s): 
Drug Trafficking
Opioids
Component(s): 
Press Release Number: 
20-015
Updated January 27, 2020